shr4640
Small moleculeexperimental
Clinical trial activity
19 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
14
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02815839)
Timeline
Indications
Mechanism of action
- Solute carrier family 22 member 12INHIBITOR
SLC22A12 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- shr4640
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06196580 | Phase 1 | Jan 4, 2024 | Hengrui Therapeutics, Inc. |
| NCT06168929 | Phase 1 | Dec 13, 2023 | Hengrui Therapeutics, Inc. |
| NCT05954169 | Phase 1 | Aug 7, 2023 | Hengrui Therapeutics, Inc. |
| NCT05513976 | Phase 2 | Sep 15, 2022 | Hengrui Therapeutics, Inc. |
| NCT04850638 | Phase 1 | Jun 28, 2021 | Hengrui Therapeutics, Inc. |
| NCT04956432 | Phase 3 | Jun 15, 2021 | Hengrui Therapeutics, Inc. |
| NCT04620408 | Phase 1 | Dec 31, 2020 | Hengrui Therapeutics, Inc., People's Liberation Army of China |
| NCT04586803 | Phase 1 | Oct 31, 2020 | Hengrui Therapeutics, Inc., Zhejiang University |
| NCT04305392 | Phase 1 | Apr 30, 2020 | Hengrui Therapeutics, Inc. |
| NCT04260373 | Phase 1 | Feb 15, 2020 | Hengrui Therapeutics, Inc. |
| NCT04180982 | Phase 2 | Dec 3, 2019 | Hengrui Therapeutics, Inc., Sichuan University |
| NCT04157959 | Phase 1 | Oct 14, 2019 | Hengrui Therapeutics, Inc. |
| NCT04052932 | Phase 3 | Aug 31, 2019 | Hengrui Therapeutics, Inc., Jiao Tong University |
| NCT03211403 | Phase 1 | Jul 4, 2017 | Atridia Pty Ltd., Linear Clinical Research |
| NCT03185793 | Phase 2 | May 11, 2017 | Hengrui Therapeutics, Inc., Jiao Tong University |
| NCT03131583 | Phase 1 | Feb 17, 2017 | Hengrui Therapeutics, Inc. |
| NCT03015948 | Phase 1 | Sep 1, 2016 | Atridia Pty Ltd., Linear Clinical Research |
| NCT02890966 | Phase 1 | Jul 1, 2016 | Hengrui Therapeutics, Inc. |
| NCT02815839 | Phase 1 | Nov 1, 2015 | Hengrui Therapeutics, Inc. |
Showing 19 of 19 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 17 | 17 | 3 | 2015 |
| Atridia Pty Ltd. | For profit | 2 | 2 | 1 | 2016 |
| Jiao Tong University | Academic/Hospital | 2 | 0 | 2 | 2017 |
| Linear Clinical Research | For profit | 2 | 0 | 1 | 2016 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2020 |
| Sichuan University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2020 |
7 organizations
Page 1 / 1